Antipsychotics in Dementia
Antipsychotic use in patients with dementia is linked to sedation, accelerated cognitive decline, and increased mortality. The mortality risk from antipsychotics is especially relevant in individuals with Lewy body dementia. Deprescribing…
1 sources - 4 claims
Antipsychotic use in patients with dementia is linked to sedation, accelerated cognitive decline, and increased mortality. The mortality risk from antipsychotics is especially relevant in individuals with Lewy body dementia. Deprescribing antipsychotics is strongly recommended for dementia-related behavioural and psychological symptoms after at least 3 months without improvement or after symptom stabilisation. Ongoing antipsychotic therapy should be regularly evaluated for all dementia patients receiving it.